Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Mar;7(2):99-105.
doi: 10.1097/COH.0b013e32834f5cf2.

HIV treatment as prevention and HPTN 052

Myron S Cohen  1 , Marybeth McCauley, Theresa R Gamble
Affiliations
Review

HIV treatment as prevention and HPTN 052

Myron S Cohen et al. Curr Opin HIV AIDS. 2012 Mar.

Abstract

Purpose of review: This review summarizes the development and implementation of a large clinical trial, HIV Prevention Trials Network (HPTN) 052, whose initial results were recently presented and published.

Recent findings: A randomized, clinical trial demonstrated that antiretroviral therapy reduces the sexual transmission of HIV in HIV-serodiscordant couples by more than 96%. The logistical challenges in preparing for and conducting such a trial were considerable.

Summary: HPTN 052 required many years of preparation, considerable collaboration between National Institute of Health and six pharmaceutical companies, and careful ongoing consideration of a large number of ethical issues. HPTN 052 revealed the magnitude of benefit when using antiretroviral therapy to prevent the transmission of HIV, and served as proof of a concept. The results have proven central to the development of new global HIV-prevention efforts.

PubMed Disclaimer

Figures

Figure 1
Figure 1
HPTN 052 Study Design
See this image and copyright information in PMC

References

    1. Burns DN, Dieffenbach CW, Vermund SH. Rethinking prevention of HIV type 1 infection. Clin Infect Dis. 2010;51:725–731. - PMC - PubMed
    1. Granich R, Crowley S, Vitoria M, et al. Highly active antiretroviral treatment for the prevention of HIV transmission. J Int AIDS Soc. 2010;13:1–8. - PMC - PubMed
    1. Cohen MS, Fidler S. HIV prevention 2010: where are we now and where are we going? Curr Opin HIV AIDS. 2010;5:265–268. - PubMed
    1. Granich R, Crowley S, Vitoria M, et al. Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and update. Curr Opin HIV AIDS. 2010;5:298–304. - PMC - PubMed
    1. Montaner JS, Hogg R, Wood E, et al. The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet. 2006;368:531–536. - PubMed

Publication types

MeSH terms

Substances